Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

NutraLife BioSciences, Inc. NLBS OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
37/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

NutraLife BioSciences, Inc. (NLBS) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 34/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Net profit margin is 0% (thin). Gross margin is 13.3% (-14.7 pp trend).

Balance sheet: total debt is $0 against $0 equity. Total assets: $0.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 40/100 (Partial), Past 0/100 (Fail), Health 100/100 (Fail), Moat 7/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

NLBS SharesGrow Score Overview

49/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 40/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 7/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — NLBS

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
40/100
NLBS: -63.7%/yr revenue is, +8.7%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
100/100
Balance sheet NLBS: Debt-to-Equity (D/E) ratio N/A, Current ratio is N/A. Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
7/100
NLBS: Gross margin is 13.3% (-14.7 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 7/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
Market Cap$17.66K
Beta (1Y)-15.21
Share Statistics
IPO Date2014-05-28
Employees12
CEOEdgar Ward
Financial Highlights & Ratios
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS67098B1070

Price Chart

Track all markets on TradingView
NLBS
NutraLife BioSciences, Inc. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic

People Also View

KOAN
KOAN
Resonate Blends, Inc.
$0.00
-10.00%
 VFRM
VFRM
Veritas Farms, Inc.
$0.00
+0.00%
 NWYU
NWYU
New You, Inc.
$0.00
+0.00%
 GSRX
GSRX
GSRX Industries Inc.
$0.00
+0.00%
 NXEN
NXEN
Nexien BioPharma, Inc.
$0.00
+0.00%
 LLY
LLY
Eli Lilly and Company
$905.13
-1.88%
 JNJ
JNJ
Johnson & Johnson
$238.67
-0.60%
 ABBV
ABBV
AbbVie Inc.
$208.43
-0.87%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message